Title:
経皮的インターベンション心臓カテーテル法のためのダビガトラン
Document Type and Number:
Japanese Patent JP2012500245
Kind Code:
A
Abstract:
The invention relates to a new use of dabigatran etexilate of formula (I) optionally in the form of the pharmaceutically acceptable salts thereof, and new medicament formulations which may be used for this purpose.
Inventors:
Riley, Paul A
Application Number:
JP2011523405A
Publication Date:
January 05, 2012
Filing Date:
August 17, 2009
Export Citation:
Assignee:
Boehringer Ingelheim International GmbH
International Classes:
A61K31/4439; A61P7/02; A61P41/00; A61P43/00; C07D401/12
Foreign References:
| WO2008009638A2 | 2008-01-24 |
Other References:
JPN6013056248; Ｅｕｒｏｐｅａｎ Ｈｅａｒｔ Ｊｏｕｒｎａｌ Ｖｏｌ．２８, 2007, ｐ．６５７-６５８
JPN6013056249; Ｂｌｏｏｄ（ＡＳＨ Ａｎｎｕａｌ Ｍｅｅｔｉｎｇ Ａｂｓｔｒａｃｔｓ） １１０, 2007, Ａｂｓｔｒａｃｔ ３９９８
JPN6013056250; Ｍｏｌｅｃｕｌａｒ Ｍｅｄｉｃｉｎｅ「生活習慣病 分子メカニズムと治療 ＶＩ」 Ｖｏｌ．３８ 臨時増刊号, 2001, ｐ．２８１-２８６
JPN6013056251; Ｐｈａｒｍａ Ｍｅｄｉｃａ Ｖｏｌ．１７， Ｎｏ．４, 1999, ｐ．８７-９１
JPN6013056253; 血栓と循環 Ｖｏｌ．６， Ｎｏ．４, 1998, ｐ．３３９-３４５
JPN6013056249; Ｂｌｏｏｄ（ＡＳＨ Ａｎｎｕａｌ Ｍｅｅｔｉｎｇ Ａｂｓｔｒａｃｔｓ） １１０, 2007, Ａｂｓｔｒａｃｔ ３９９８
JPN6013056250; Ｍｏｌｅｃｕｌａｒ Ｍｅｄｉｃｉｎｅ「生活習慣病 分子メカニズムと治療 ＶＩ」 Ｖｏｌ．３８ 臨時増刊号, 2001, ｐ．２８１-２８６
JPN6013056251; Ｐｈａｒｍａ Ｍｅｄｉｃａ Ｖｏｌ．１７， Ｎｏ．４, 1999, ｐ．８７-９１
JPN6013056253; 血栓と循環 Ｖｏｌ．６， Ｎｏ．４, 1998, ｐ．３３９-３４５
Attorney, Agent or Firm:
Hajime Tsukuni
Fusayuki Saito
Fusayuki Saito